APA (7th ed.) Citation

MA, L., Z, C., Y, B., K, B., J, K., M, T., . . . DW, H. (2021). Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(7), e2153. https://doi.org/10.1093/cid/ciaa1219

Chicago Style (17th ed.) Citation

MA, Leonard, et al. "Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 73, no. 7 (2021): e2153. https://doi.org/10.1093/cid/ciaa1219.

MLA (9th ed.) Citation

MA, Leonard, et al. "Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 73, no. 7, 2021, p. e2153, https://doi.org/10.1093/cid/ciaa1219.